Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21733336 | 0.94 | GGPS1 (0.35) | GGPS1ALDH1A1 | |
| SCHEMBL23505460 | 0.83 | GGPS1 (0.48) | GGPS1 | |
| SCHEMBL27334232 | 0.81 | GGPS1 (0.52) | GGPS1TSHR | |
| SCHEMBL4492650 | 0.80 | PIK3CD (0.46) | GGPS1SMN1; SMN2LMNAALDH1A1HSD17B10 | |
| SCHEMBL19936946 | 0.80 | GGPS1 (0.41) | GGPS1 | |
| SCHEMBL19264171 | 0.79 | GGPS1 (0.46) | GGPS1 | |
| SCHEMBL23266333 | 0.79 | LMNA (0.37) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL22856338 | 0.79 | LMNA (0.41) | GGPS1LMNA | |
| SCHEMBL23568339 | 0.79 | LMNA (0.41) | GGPS1LMNA | |
| SCHEMBL23567936 | 0.78 | LMNA (0.39) | GGPS1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400491-A1 | NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION | Themedium Therapeutics Co., Ltd (CN) | 2024-07-17 | — | — | EP | disclosed |